Significant novel findings established verapamil as a successful therapeutic approach to target loss of beta cell function caused by type 1 diabetes

New research shows that an experimental HIV-1 vaccine regimen is well-tolerated

Big benefits expected in battle against cancer, autism, Alzheimer's, and more

Lab Manager editor Lauren Everett speaks with Alejandro Amador, COO of Ammon Labs.

Investigational drug works differently than addictive opioid drugs

Veterinary flea and tick drugs kill mosquitoes and other insects that carry diseases between humans

Low-dose aspirin regimen could reduce Alzheimer's disease pathology

Patients with Type 2 diabetes who were treated with the newer generation of insulin analog drugs did not have substantially better outcomes than those treated with less costly human insulin

Alcohol abuse is among the leading causes of preventable death in the United States, killing more than 88,000 people a year

Collaboration combines expertise in novel chemical compound synthesis with GMP manufacture in drug discovery

Combinations of cancer drugs can be quickly and cheaply tested on tumor cells using a novel device developed by EMBL scientists

PhoreMost has built a pipeline of novel targets and early drug discovery programs using its next-generation “SITESEEKER^®” phenotypic screening platform